SCHEMBL6958994

SCHEMBL6958994

Cc1ccccc1-c1cc(O)c(SCc2ccccc2)c(=O)o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
EGFR P00533 2/20 0.45
NPC1 O15118 2/20 0.45
MAPK1 P28482 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ATM Q13315 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ELANE P08246 4/20 0.42
S100A4 P26447 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
DAO P14920 3/20 0.39
HSD17B10 Q99714 1/20 0.37
CNR2 P34972 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
NQO1 P15559 1/20 0.36
MAPT P10636 2/20 0.35
PKM P14618 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6956094 0.88 AKR1C3 (0.46) HPGDEGFRMAPK1TDP1SMN1; SMN2
SCHEMBL6960015 0.88 ELANE (0.44) HPGDEGFRNPC1MAPK1TDP1
SCHEMBL6961428 0.85 MEN1 (0.45) HPGDNPC1TDP1ATMRAB9A
SCHEMBL6954431 0.84 EGFR (0.40) HPGDEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL6964669 0.84 ELANE (0.39) HPGDEGFRNPC1SMN1; SMN2ELANE
SCHEMBL6954786 0.83 SMN1; SMN2 (0.50) HPGDMAPK1SMN1; SMN2ELANEKDM4E
SCHEMBL6963460 0.82 EGFR (0.41) HPGDEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL6963367 0.82 POLB (0.45) HPGDEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL11788874 0.81 DAO (0.43) EGFRSMN1; SMN2ELANES100A4ALDH1A1
SCHEMBL6959887 0.81 S100A4 (0.36) HPGDEGFRS100A4KDM4EDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed